Developmental biology of erythropoiesis

Blood Reviews

Volumn 12, Issue 2, 1998, Pages 106-114

  Palis, J ^a   Segel, G B ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROCYTE ANTIGEN;

ALPHA THALASSEMIA; ANEMIA; BETA THALASSEMIA; BLOOD VESSEL; DEVELOPMENTAL BIOLOGY; EMBRYO; ERYTHROBLAST; ERYTHROCYTE; ERYTHROPOIESIS; FETUS; GLOBIN GENE; HEMATOPOIETIC STEM CELL; HUMAN; LIVER; NEWBORN; PRIORITY JOURNAL; REVIEW; THIRD TRIMESTER PREGNANCY; UMBILICAL CORD BLOOD; YOLK SAC;

EID: 0031868228     PISSN: 0268960X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0268-960X(98)90022-4     Document Type: Article

References (57)

1. Takashina T. Haemopoiesis in the human yolk sac. J Anat 1987; 151: 125-135.
2. Shivdasani RA, Orkin SH. The transcriptional control of hematopoiesis. Blood 1996; 87: 4025-4039.
3. Peschle C, Migliaccio G, Lazzaro D, et al. Hemopoietic development in human embryos. Blood Cells 1984; 10:427-441.
4. Peschle C, Migliaccio G, Migliaccio AR, et al. Identification and characterization of three classes of erythroid progenitors in human fetal liver. Blood 1981; 58:565-572.
5. Orlic D, Bodine DM. What defines a pluripotent hematopoietic stem cell (PHSC): will the real PHSC please stand up. Blood 1994; 84:3991-3994.
6. Cairo MS, Wagner JE. Placental and/or umbilical cord blood: an alternative source of hematopoietic stem cells for transplantation. Blood 1997; 90:4665-4678.
7. Kurtzberg J, Laughlin M, Graham ML. et al. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. New Engl J Med 1996; 335:157-166.
8. Kelly P, Kurtzberg J, Vichinsky E, Lubin B. Umbilical cord blood stem cells: application for the treatment of patients with hemoglobinopathies. J Pediatr 1997; 130:695-703.
9. Muller AM, Medvinsky A, Strouboulis J, Grosveld F, Dzierzak E. Development of hematopoietic stem cell activity in the mouse embryo. Immunity 1994; 1:291-301.
10. Yoder MC, Hiatt K, Dutt P, Mukherjee P, Bodine DM, Orlic D. Characterization of definitive lymphohematopoietic stem cells in the day 9 murine yolk sac. Immunity 1997; 7:335-344.
11. Moore MAS, Metcalf D. Ontogeny of the haemopoietic system: yolk sac origin in vivo and in vitro colony forming cells in the developing mouse embryo. Br J Haematol 1970; 18:279-296.
12. Dieterlen-Lievre F. Embryonic chimeras and hematopoietic system development. Bone Marrow Transplantation 1992; 9:30-35.
13. Smith RA, Glomski CA. 'Hemogenic endothelium' of the embryonic aorta: does it exist? Dev Comparative Immunol 1982;6:359-368.
14. Tavian M, Coulombel L, Luton D, San Clemente H, Dieterlen-Lievre F, Peault B. Aorta-associated CD-34 + hematopoietic cells in the early human embryo. Blood 1996; 87:67-72.
15. Delassus S, Cumano A. Circulation of hematopoietic progenitors in the mouse embryo. Immunity 1996; 4:97-106.
16. Medvinsky A, Dzierzak E. Definitive hematopoiesis is autonomously initiated by the AGM region. Cell 1996; 86:897-906.
17. Kennedy M, Firpo M, Choi K, et al. Identification of a common precursor for primitive and definitive hematopoiesis. Nature 1997; 386:488-493.
18. Blazar BR, Taylor PA, Vallera DA. Adult bone marrow-derived pluripotent hematopoietic stem cells are engraftable when transferred in utero into moderately anemic fetal recipients. Blood 1995; 85:833-841.
19. Zanjani ED, Ascensao JL, Flake AW, Harrison MR, Tavassoli M. The fetus as an optimal donor and recipient of hemopoietic stem cells. Bone Marrow Transplantation 1992; 10:107-114.
20. Cowan MJ, Golbus M. In utero hematopoietic stem cell transplants for inherited diseases. Am J Pediatr Hematol/Oncol 1994; 16:35-42.
21. Sawyer ST, Penta K. Erythropoietin cell biology. Hematol Oncol Clin North Am 1994; 8:895-911.
22. Cole RJ, Paul J. The effects of erythropoietin on haem synthesis in mouse yolk sac and cultured foetal liver cells. J Embryoland Exp Morphol 1966; 15:245-260.
23. Koury MJ, Bondurant MC, Graber SE, Sawyer ST. Erythropoietin messenger RNA levels in developing mice and transfer of 1251-erythropoietin by the placenta. J Clin Invest 1988; 82:154-159.
24. Yu H, Bauer B, Lipke G, Phillips R, Van Zant G. Apoptosis and hematopoiesis in murine fetal liver. Blood 1993; 81:373-384.
25. Wu H, Liu X. Jaenisch R. Lodish HF. Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor. Cell 1995; 83:59-67.
26. Zanjani ED. Ascensao JL. Erythropoietin. Transfusion 1989; 29:46-57.
27. Weinberg R. He LY. Alter BP. Erythropoiesis is distinct at each stage of ontogeny. Pediatr Res 1992; 31:170-175.
28. Matoth Y, Zaizov R, Varsano I. Acta Pediatr Scandinav 1971; 60:317-323.
29. Kling PJ, Schmidt RL, Roberts RA. Widness JA. J Pediatr 1996; 128:791-796.
30. Stockman J, Graeber JE, Clark DA, McClellan K. Garcia JF. Kavey RE. Anemia of prematurity; determinants of the erythropoietin response. J Pediatr 1984; 105:786-792.
31. Dallman PR. Erythropoietin and the anemia of prematurity. J Pediatr 1984; 105:756-757.
32. Eckardt K-U. Ratcliffe PJ, Tan CC. Bauer C, Kurtz A. Age dependent expression of the erythropoietin gene in rat liver and kidneys. J Clin Invest 1992; 89:753-760.
33. Gallagher PG, Ehrenkranz RA. Erythropoietin therapy for anemia of prematurity. Clinics Perinatol 1993; 20:169-191.
34. Starck J, Romana R, Bhargava A. et al. Developmental regulation of human γ- and β-globin genes in the absence of the locus control region. Blood 1994; 84:1656-1665.
35. Wood WG, Howes S, Bunch C. Developmental clocks and hemoglobin switching. Progress Clin Biol Res 1987; 251:521-529.
36. Bromberg YN, Abrahamov A, Salzberger M. The effect of maternal anoxemia on the foetal hemoglobin of the newborn. J Obstet Gynecol Br Commonw 1956; 63:875-877.
37. Perrine SP, Greene MF, Faller DV. Delay in the fetal globin switch in infants of diabetic mothers. New Engl J Med 1985; 312:334-338.
38. Wilson MG, Schroeder WA, Graves DA. Postnatal change of hemoglobin F and A2 in infants with Down's syndrome (G trisomy). Pediatrics 1968; 42:349-353.
39. Olivieri NF. Fetal erythropoiesis and the diagnosis and treatment of hemoglobin disorders in the fetus and child. Semin Perinatol 1997; 21:63-69.
40. Metaxotou-Mavroraati AD, Antonopoulou HK, Laskari SA, Tsiarta HK, Ladis VA, Kattamis CA. Developmental changes in hemoglobin F levels during the first two years of life in normal and heterozygous β-thalassemia infants. Pediatrics 1982; 69:734-738.
41. Pirastu M, Kan YW, Lin CC, Baine RM, Holbrook CT. Hemolytic disease of the newborn caused by a new deletion of the entire β-globin cluster. J Clin Invest 1983; 72:602-609.
42. Bollekens JA, Forget BG. δβ thalassemia and hereditary persistence of fetal hemoglobin. Hematol Oncol Clin North Am 1991; 5:399-422.
43. Gollin YG, Copel JA. Management of the Rh-sensitized mother. Clin Perinatol 1995; 22:545-559.
44. Peterec SM. Management of neonatal Rh disease. Clin Perinatol 1995; 22:561-592.
45. Bowman J. The management of hemolytic disease in the fetus and newborn. Semin Perinatol 1997; 21:39-44.
46. Race RR, Sanger R. Blood Groups in Man. London: Blackwell, 1975.
47. Bierhuizen MFA, Mattei MG, Fukuda M. Expression of the developmental I antigen by a cloned human cDNA encoding a member of a b-1,6-N-acetylglucosaminyl-transferase gene family. Genes Dev 1993; 7:468-478.
48. Hyland CA, Walter LC, Saul A. Identification and analysis of Rh genes: application of PCR and RFLP typing tests. Transfusion Med Reviews 1995; 9:289-301.
49. Lee S, Bennett PR, Overton T, Warwick R, Wu X, Redman CM. Prenatal diagnosis of Kell blood group genotypes: KEL1 and KEL2. Am J Obstet Gynecol 1996; 175:455-459.
50. Brierley CH, Burchell B. Human UDP-glucuronosyl transferases: chemical defence, jaundice and gene therapy. Bioassays 1993; 15:749-754.
51. Brugnara C, Platt OS. The neonatal erythrocyte and its disorders. In: Nathan DG, Orkin SH, eds. Nathan and Oski's Hematology of infancy and childhood. Philadelphia: WB Saunders, 1998:19-54.
52. Beutler E. Glucose-6-phosphate dehydrogenase deficiency. N Engl J Med 1991; 324:169-174.
53. Lipton JM, Kudisch M, Gross R, Nathan DG. Defective erythroid progenitor differentiation system in congenital hypoplastic (Diamond-Blackfan) anemia. Blood 1986; 67:962-668.
54. Dianzani I. Garelli E, Dompe C, et al. Mutations in the erythropoietin receptor gene are not a common cause of Diamond-Blackfan anemia. Blood 1996; 87:2568-2572.
55. Freedman MH. Erythropoioesis in Diamond-Blackfan anemia and the role of the interleukin 3 and steel factor. Stem Cells 1993; 11 Suppl 2:98-104.
56. Nathan DG, Alter BP. F-cell regulation. Annals New York Acad Science 1980; 344:219-232.
57. Blau CA, Constantoulakis P, Al-Khatti A, et al. Fetal hemoglobin in acute and chronic states of erythroid expansion. Blood 1993; 81:227-233.